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Store-operated calcium (Ca2+) entry (SOCE) can be mediated by two novel proteins,
STIM/Orai. We have previously demonstrated that members of the TRPC family, putative
basal and store operated calcium entry channels, are present in human myometrium and
regulated by labor associated stimuli IL-1β and mechanical stretch. Although STIM and Orai
isoforms (1-3) have been reported in other smooth muscle cell types, there is little known
about the expression or gestational regulation of STIM and Orai expression in human
myometrium. Total RNA was isolated from lower segment human myometrial biopsies
obtained at Cesarean section fromwomen at the time of preterm no labor (PTNL), preterm
labor (PTL), term non-labor (TNL), and term with labor (TL); primary cultured human
uterine smooth muscle cells, and a human myometrial cell line (hTERT-HM). STIM1-2,
and Orai1-3 mRNA expression was assessed by quantitative real-time PCR. All five genes
were expressed in myometrial tissue and cultured cells. STIM1-2 and Orai2-3 expression
was significantly lower in cultured cells compared tissue. This has implications with regard
investigation of the contribution of these proteins in cultured cells. Orai2 was the most
abundant Orai isoform in human myometrium. Expression of STIM1-2/Orai1-3 did not alter
with the onset of labor. Orai1 mRNA expression in cultured cells was enhanced by IL-1β
treatment. This novel report of STIM1-2 and Orai1-3 mRNA expression in pregnant human
myometrium and Orai1 regulation by IL-1β indicates a potential role for these proteins in
calcium signaling in human myometrium during pregnancy.
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INTRODUCTION
Intracellular calcium signals regulate a variety of important phys-
iological processes including gene transcription, cell growth, and
contraction. Such signals originate either from an influx of cal-
cium from the extracellular space [e.g., voltage-gated calcium
channels, store-operated calcium entry (SOCE) and receptor-
operated calcium entry (ROCE) pathways] and/or via release
from intracellular calcium stores (Putney, 1986, 2013; Parekh and
Penner, 1997).
In excitable cells, including myometrium, calcium entry via
voltage-gated calcium channels form the predominant calcium
entry pathway involved in contraction, but there is evidence
for functional SOCE and ROCE in myometrial tissue and cells
(Sanborn, 1995, 2007a,b; Tribe, 2001; Dalrymple et al., 2004,
2007; Shmygol and Wray, 2004; Noble et al., 2009). We hypoth-
esized that these pathways may not only contribute to prolon-
gation of contraction events, but also to uterine smooth muscle
growth and provision of discrete calcium signals required to
modulate gene expression throughout gestation and at labor
onset.
It was originally proposed that transient receptor poten-
tial cation channel subfamily C (TRPC) channels contribute to
SOCE and ROCE (Birnbaumer et al., 1996; Zhu et al., 1996).
Indeed, we and others have identified TRPC homologues in
human myometrium from non-pregnant and pregnant women
(Dalrymple et al., 2002; Yang et al., 2002; Ku et al., 2006).
Furthermore, we have also shown that TRPC3 expression is
up-regulated by mechanical strain and the pro-inflammatory
cytokine IL-1β, stimulators of myometrial growth and activa-
tion, in cultured human myometrial cells (Dalrymple et al., 2004,
2007).
However, two other gene families, STIM (1-2) and Orai (1-3)
have emerged as the main candidates underlying SOCE com-
plexes (Manji et al., 2001; Williams et al., 2001; Marchant,
2005; Roos et al., 2005; Zhang et al., 2005; Peinelt et al.,
2006; Spassova et al., 2006; Soboloff et al., 2006). STIM1
senses Ca2+ store depletion of the endoplasmic reticulum (ER)
and relocates to the plasma membrane to interact with Orai1
channels and activate Ca2+ entry (Zhang et al., 2005). The
functional role of STIM2 is less well defined. Knockdown of
STIM2 in several cell types has little or no effect on SOCE
(Liou et al., 2005; Roos et al., 2005; Soboloff et al., 2006; Wu
et al., 2006; Oh-Hora et al., 2008), although STIM2 has also
been reported to be involved in the regulation of basal and
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cytosolic and ER Ca2+ levels (Brandman et al., 2007; Lu et al.,
2009).
Orai proteins have been firmly established as the
Ca2+-selective pores of CRAC channels. (Feske et al., 2006;
Prakriya et al., 2006; Soboloff et al., 2006; Vig et al., 2006;
Fahrner et al., 2013), but as SOC currents display distinctly
different characteristics in excitable cells, it has yet to be fully
established whether Orai channels or STIM can also mediate this
more non-selective cation current alone or whether interactions
between Orai1 and TRPC1/TRPC3 (Zbidi et al., 2009; Cheng
et al., 2011) and/or post-translational modification of Orai may
also mediate altered channel selectivity in excitable cells.
Peel et al. (2006, 2008) have demonstrated a contribution
of STIM1 and Orai1 to non-selective SOC currents in cultured
human airway smooth muscle cells. There is also evidence for
Orai and STIM in other smooth muscle cell types (Trebak, 2012;
Ruhle and Trebak, 2013). In light of this emerging role of Orai
and STIM in excitable cells, the aims of the current study were
to: (i) determine the mRNA expression profiles of STIM1-2 and
Orai1-3 and in pregnant human myometrial tissue and primary
cultured human uterine smooth muscle cells and (ii) exam-
ine the effect of the labor-associated cytokine IL-1β on these
genes.
MATERIALS AND METHODS
MATERIALS
STIM1 and β-actin antibodies were purchased from Abcam
(Cambridge, UK). Orai1 antibody was purchased from Axxora
(Nottingham, UK.) HRP conjugated goat anti-rabbit IgG
was purchased from Pierce (Chester, UK). HRP conjugated
goat anti-mouse IgG was purchased from BD Transduction
Laboratories (Cowley, UK). ECL western blotting detection
reagent and Hyperfilm ECL were obtained from GE Healthcare
Life Sciences (Buckinghamshire, UK). SDS buffer was purchased
from National Diagnostics (Hull, UK). SensiMix Plus SYBR
was purchased from Bioline (London, UK). All other mate-
rials were purchased from Sigma (Poole, UK) or Invitrogen
(Paisely, UK).
SUBJECTS
Human myometrial biopsies were obtained from women with-
out any underlying conditions, undergoing elective Cesarean
section at term (39.7 ± 0.4 weeks of gestation) with informed
written consent and institutional Ethics Committee approval
(St Thomas’ Research Ethics Committee – EC001/137; Office of
Medical Bioethics, University of Calgary). In addition, lower seg-
ment human myometrium was obtained from four groups of
women at the time of Cesarean section under the conditions
of preterm no labor (PTNL; 29.2 ± 1.7 weeks), preterm with
labor (PTL; 30.0 ± 2.1 weeks), term no labor (TNL; 39.5 ± 0.4
weeks), and term with labor (TL; 39.1 ± 0.6 weeks). Whole
myometrial tissue was either snap frozen and stored at −80◦C
or used immediately for cell culture. RNA was extracted from
whole tissue, primary cultured myometrial cells (P0) and pas-
saged (P2) myometrial cells and a human myometrial cell line
derived from the non-pregnant uterus (hTERT-HM) (Condon
et al., 2002).
ISOLATION AND PRIMARY CULTURE OF HUMAN UTERINE SMOOTH
MUSCLE CELLS (hUSMCs)
hUSMCs were isolated as previously described (Tribe et al.,
2000). Briefly, small segments of myometrium were dissected
and chopped 1–2mm3 pieces and incubated for 30–40min
in Dulbecco’s modified Eagles medium (DMEM) containing
1mg/ml collagenase 1A, 1mg/ml collagenase XI plus 0.1% BSA,
penicillin (50 units/mL), and streptomycin (50mg/mL). Cells
were dislodged using a Pasteur pipette and then filtered through
a 45μm sterile filter, and washed twice in DMEM containing
10% fetal calf serum (FCS) by centrifugation (450 × g 5min).
The cell pellet was suspended in DMEM supplemented with
10% FCS, penicillin (25 units/ml), and streptomycin (25mg/ml).
Primary myocytes (P0) were seeded in six-well plates and incu-
bated at 37◦C in a humidified atmosphere of 95% air/5% CO2. P2
myocytes were cultured in T25 flasks and then passaged in 6-well
plates. After the first 2 days of culture, media was replaced with
DMEM supplemented with 5% FCS, penicillin (25 units/ml), and
streptomycin (25mg/ml). The medium was changed every 2 days
until cells were ∼80% confluent. Cells were then passaged to P2
or serum-deprived for 24 h prior to RNA/protein extraction.
QUANTITATIVE RT-PCR
Frozen myometrial tissue (∼30mg) was homogenized using a
Qiagen Tissue Lyser. Total RNA was extracted from myome-
trial tissue and cultured uterine myocytes using the RNeasy mini
kit (Qiagen, UK) according to the manufacturer’s instructions.
Complementary deoxyribonucleic acid (cDNA) was synthesized
using an Omniscript RT Kit (Qiagen, UK). Real-time polymerase
chain reaction (PCR) was carried out with the use of SYBR Green
chemistry (Bioline) on a RotorGene 6000 (Qiagen, UK) using
the primers as listed in Table 1. A pre-PCR cycle was run for
10min at 95◦C followed by 35 cycles of 95◦C for 15 s, 60◦C for
30 s, and 72◦C for 50 s followed by a final extension at 72◦C
for 15 s. Melt curve analysis was performed to confirm the pres-
ence of one single product. Cycle threshold (CT) values were
used for analysis, and abundance data were obtained by the use
of quantified cDNA to generate a standard curve. All unknowns
fell within the dynamic range of the standard curve. Standards
were quantified using densitometry, and tenfold serial dilution
from 1010 to 101 copies was run in parallel with the samples.
Data for the genes of interest were then expressed relative to
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) which was
the most stable housekeeper from a panel of 3 (GAPDH, β-actin
and β-2 microglobulin). All PCR products were sequenced to
confirm identity.
IDENTIFICATION OF STIM1 AND Orai1 IN MYOMETRIAL TISSUE AND
CULTURED UTERINE SMOOTH MUSCLE CELLS BY WESTERN BLOTTING
Human myometrial tissues were homogenized using a Tissue
Lyser II (Qiagen) at 25Hz for 3min in 20μl lysis buffer/mg of
tissue [10mM of HEPES-KOH (pH 7); 1mM of dithiothreitol;
1% nonident-P40, and protease-inhibitor cocktail (COMPLETE
tablets; Boehringer-Mannheim Biochemical, Lewes, Sussex,
UK)]. Tissue lysates were then transferred to 1.5ml microfuge
tubes and centrifuged for 1min at 12470 × g to remove any tis-
sue debris. Uterine smooth muscle cells lysates were prepared by
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Table 1 | Real-time PCR primer sequences.
Gene Accession number Primer sequence Amplicon length
STIM1 NM_003156.2 (+) 5′-GCTCCTCTGGGGACTCCT-3′
(−) 5′-CAATTCGGCAAAACTCTGCT-3′
125 bp
STIM2 NM_020860.1 (+) 5′-GAC GTC AGT ATG CAG AAC AGG A-3′
(−) 5′-TCA AAT TCT TTT TCG GCC TTT-3′
125 bp
Orai1 NM_032790.2 (+) 5′-ACC TCG GCT CTG CTC TCC-3′
(−) 5′-GAT CAT GAG CGC AAA CAG G-3′
147 bp
Orai2 NM_032831.1 (+) 5′-TAC CTG AGC AGG GCC AAG-3′
(−) 5′-GGT ACT GGT ACT GCG TCT CAA-3′
109 bp
Orai3 NM_152288.2 (+) 5′-ACG TCT GCC TTG CTC TCG-3′
(−) 5′-GAG TGC AAA GAG GTG CAC AG-3′
141 bp
PTGS2 NM_000963.2 (+) 5′-TCA CGC ATC AGT TTT TCA AGA-3′
(−) 5′-TCA CCG TTA ATA TGA TTT AAG TCC AC-3′
94 bp
GAPDH NM_002046.3 (+) 5′-GGAAGCTTGTCATCAATGGAA-3′
(−) 5′-TGGACTCCACGACGTACTCA-3′
102 bp
removing culturemedium and rising twice with ice-cold PBS. The
cells were then aspirated to dryness and 100μl of lysis buffer was
added to each well and incubated on ice for 5min. Cells were
then scraped and the lysate removed and placed in to a 1.5ml
microfuge tube and centrifuged for 1min at 12,470× g to remove
any cell debris. Tissue and whole cell lysate protein content
was quantified using a NanoDrop ND-1000 spectrophotometer
(Labtech). Lysates were then diluted 1:1 with× 2 Laemmli sample
buffer (Sigma) then boiled at 95◦C for 5min. Samples were then
stored at -20◦C until required, when they were thawed, then re-
boiled for 5min at 95◦C and centrifuged at 12,470 × g for 1min
prior to electrophoresis.
SDS-PAGE ANDWESTERN IMMUNOBLOTTING
Tissue/cell lysate proteins were separated using 10% Tris-Glycine
precast gels (Invitrogen) using the XCell SureLock™ Mini-Cell
system (Invitrogen). Following electrophoresis, proteins were
transferred to Immobilion™-P transfer membrane (Millipore)
using the XCell SureLock™ Mini-Cell blotting module wet trans-
fer blotting system. After transfer of proteins to the membrane,
non-specific sites were blocked by soaking themembrane in 100%
methanol for 10 s and then allowing the membrane to dry com-
pletely for ∼15min. Membranes were then incubated for at least
5 h with maximum speed of agitation at room temperature or
overnight at 4◦C with the appropriate primary antibody diluted
in tris-buffered saline with tween [TBS-T: 50mM Tris, 150mM
NaCl, 0.2% (v/v) Tween-20, pH 7.4] containing 10% (w/v) BSA
(STIM1- 1μg/ml; Orai1-1μg/ml). Membranes were then washed
for 3 × 20min in TBS-T. Following the incubation of the mem-
brane in a 1:10,000 dilution in TBS-T of horseradish peroxidase
(HRP)-conjugated secondary antibody for 45min, themembrane
was washed a further 3 × 20min in TBS-T. Immunoreactive
proteins were visualized using enhanced chemiluminescence
(ECL™) (Amersham) according to the manufacturer’s instruc-
tions. Densitometric quantification of immunoreactive bands was
carried out using BioRad Molecular Quantity One software, ver-
sion 4.4.0. To verify equal protein loading, blots were also probed
with β-actin antibody.
STATISTICAL ANALYSIS
Data were analyzed by analysis of variance (ANOVA) with
repeated measures, with Bonferroni multiple comparison test or
Student’s t-test as appropriate using GraphPad Prism version 5.02
(La Jolla, CA). The effect of IL-1β on gene expression was ana-
lyzed using linear regression on the log of concentration, testing
for a linear interaction between treatment and time. The stan-
dard errors were adjusted using the Huber sandwich estimator
(Rogers, 1993). Data expressed as mean ± standard error of the
mean (s.e.m). P < 0.05 was accepted as significant.
RESULTS
STIM1 AND STIM2 ARE EXPRESSED IN HUMANMYOMETRIAL TISSUE
AND CULTURED hUSMCs
STIM1 mRNA was detected in myometrial tissue and cul-
tured cells (Figure 1A). Expression was significantly higher in
myometrial tissue compared to cells cultured from P0 and
P2 (term-pregnant) and hTERT-HM (non-pregnant) hUSMCs.
STIM1 mRNA expression in hTERT-HM uterine smooth mus-
cle cells was significantly less than expression in P0 or P2 cells
(P < 0.0002). STIM2 mRNA was also detected, with signifi-
cantly greater expression in myometrial tissue compared to term-
pregnant and non-pregnant hUSMCs (P < 0.05) (Figure 1B).
Similarly STIM2 mRNA expression was significantly less in
hTERT-HM compared to P0 and P2 uterine smooth muscle cells
(P < 0.05).
Orai1, Orai2, AND Orai3 mRNA ARE EXPRESSED IN HUMAN
MYOMETRIAL TISSUE AND CULTURED hUSMCs
All three Orai isoforms (Orai1-3) mRNA were detected
in myometrial tissue and cultured hUSMCs (Figures 2A–C).
However, in contrast to STIM1 and 2 mRNA expression, Orai1
mRNA expression levels (Figure 2A), were similar in myome-
trial tissue and cultured cells, with no difference in expres-
sion between term-pregnant and non-pregnant hUSMCs being
detected. Orai2 mRNA expression was significantly higher in
tissue when compared to cultured cells (P < 0.01). However,
expression in hTERT-HM was significantly reduced compared
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FIGURE 1 | STIM1 and STIM2 mRNA are expressed in term pregnant
human myometrial tissue and cultured term pregnant (P0/P2) and
non-pregnant (hTERT-HM) hUSMCs. mRNA from myometrial tissue and
serum-deprived hUSMCs was extracted and assessed for (A) STIM1 and
(B) STIM2 expression. Data are expressed as copy number ± s.e.m.,
normalized to GAPDH (n = 6 tissues or cell cultures). ∗P < 0.05;
∗∗P < 0.01; ∗∗∗P < 0.001 compared to tissue expression.
to P0 (P < 0.01) and P2 (P < 0.05) cultured myometrial cells.
Orai3 expression was significantly higher in myometrial tissue
than cultured cells with hTERT-HM exhibiting the lowest level
of expression.
IDENTIFICATION OF STIM1 AND Orai1 PROTEIN IN MYOMETRIAL
TISSUE AND CULTURED hUSMCs
Both STIM1 and Orai1 proteins are expressed in tissue as well as
cultured cells (Figure 3).
STIM1/2 AND Orai1-3 mRNA EXPRESSION IN PREGNANT HUMAN
MYOMETRIAL TISSUE
All genes were expressed in both preterm and term myometrial
tissue. There was no difference in the expression of these genes
FIGURE 2 | Orai1-3 mRNA is expressed in term pregnant human
myometrial tissue and cultured term pregnant (P0/P2) and
non-pregnant (hTERT-HM) hUSMCs. mRNA from myometrial tissue and
serum-deprived hUSMCs was extracted and assessed for (A) Orai1, (B)
Orai2, and (C) Orai3 expression. Data are expressed as mean ± s.e.m.,
normalized to GAPDH (n = 6 tissues or cell cultures). ∗P < 0.05;
∗∗P < 0.01; ∗∗∗P < 0.001.
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across gestation or with the onset of labor. Expression was in
the order of STIM1 > STIM2 and Orai2 > Orai3 > Orai1 in all
groups studied (Figures 4A–D).
EFFECT OF IL-1β ON STIM1-2 AND Orai1-3 mRNA EXPRESSION IN
PRIMARY hUSMCs
The impact of the labor-associated cytokine IL-1β treatment
on STIM1-2 and Orai1-3 mRNA expression levels was also
assessed (Figure 5). Six hours treatment with IL-1β (10 ng/ml)
did not modulate STIM1-2 mRNA expression (Figures 5A,B).
IL-1β treatment increased Orai1 mRNA expression (1.4-fold
FIGURE 3 | STIM1 and Orai1 protein expression in human myometrium
and cultured hUSMCs. Human myometrial tissue and whole cell lysates
proteins were separated by SDS-PAGE and probed for STIM1, Orai1, and
β-actin (loading control). Representative blots are shown with each band
representing tissue/cells from individual patients.
per hour up to 2 h; 95% CI: 1.1–1.7; P = 0.013) (Figure 5C).
IL-1β had no effect on either Orai2 or Orai3 mRNA expression
(Figures 5D,E). Prostaglandin-endoperoxide synthase 2 (PTGS2)
mRNA expression (positive control) was significantly increased at
4 and 6 h incubation from the same experiment (Figure 5F).
EFFECT OF IL-1β ON Orai1 PROTEIN EXPRESSION IN PRIMARY hUSMCs
Given that IL-1β significantly enhanced Orai1 mRNA expres-
sion, we also investigated the effect of this cytokine on Orai1
protein expression in primary hUSMCs. Although the data did
not achieve statistical significance, 7 out of 8 patients showed
an increase in Orai1 expression with IL-1β (Figure 6). However,
there was great inter-subject variation in the magnitude of the
response to IL-1β.
DISCUSSION
In the present study, we have clearly demonstrated that STIM and
Orai isoforms are expressed in pregnant human myometrial tis-
sue. We show for the first time, STIM (1-2) and Orai (1-3) gene
expression in pregnant preterm and term human myometrial tis-
sue taken prior to and after the onset of labor. The identification
of these genes supports previous observations of their presence
in cultured human myometrial cells (Murtazina et al., 2011) and
other smooth muscle cell types (Peel et al., 2006, 2008; Berra-
Romani et al., 2008; Trebak, 2012; Ruhle and Trebak, 2013) and
their role in SOCE (Soboloff et al., 2006; Muik et al., 2009; Yuan
et al., 2009).
FIGURE 4 | STIM1/2 and Orai1-3 mRNA expression in pregnant human myometrial tissue taken from women at Cesarean section who were (A)
preterm in labor (PTL, n = 4), (B) preterm but not in non labor (PTNL, n = 5), (C) term but not in labor (TNL, n = 6) and (D) term in labor (TL, n = 6).
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FIGURE 5 | Effect of IL-1β on STIM1-2 and Orai1-3 mRNA
expression in primary hUSMCs. Serum-deprived primary hUSMCs
were incubated in the presence or absence of 10 ng/ml IL-1β for up
to 6 h and mRNA extracted and assessed for (A) STIM1, (B) STIM2,
(C) Orai1, (D) Orai2, (E) Orai3, and (F) PTGS2 expression. Data are
expressed as log normalized copy number (A–E) or percentage of
time-matched control (F), mean ± s.e.m., (cells from n = 6 patients).
∗∗P < 0.01; ∗∗∗P < 0.001.
Assessment of mRNA abundance indicated that STIM1
expression is greater than STIM2 in term-pregnant myometrial
tissue and cultured cells. These data are similar to a previous
report of STIM1 and 2 mRNA expression in cultured human
myometrial cells and immortalized smooth muscle cells derived
from term pregnant human myometrium (Murtazina et al.,
2011). The presence of STIM1 protein in tissue and cultured cells
was confirmed by Western blot. These data confirm that STIM1
is the more abundant isoform in human myometrium tissue and
cells.
In myometrial tissue, we identified an Orai mRNA profile
of Orai2 > Orai3 > Orai1 irrespective of gestation or labor.
Interestingly, this pattern of expression was slightly modified in
cultured hUSMCs (Orai3 > Orai2 > Orai1) and overall there
was greater expression of Orai2-3 in tissue samples compared
to cells. The switch in isoform dominance between tissue and
primary cultured cells could indicate that there is contribution
to the Orai1-3 signal in tissue from other cell types such as
mast cells (Ashmole et al., 2013) or that there has either been a
phenotypic change in culture. The significant changes observed
in Orai isoform expression in cultured cells compared to tissue
should be taken into consideration for future investigations into
the role of these proteins in cultured cells. Orai2 and 3 appear to
have distinct functional properties compared to Orai1. Much less
is known about the “true” functional relevance of Orai2 and 3
(Hoth and Niemeyer, 2013). However, a recent study by Bandara
et al. (2013) provides evidence that Orai2 functions as a Ca2+
leak channel in the ER. Orai3 has been shown to compensate for
the loss of functional Orai1 (DeHaven et al., 2007; Gwack et al.,
2007; Lis et al., 2007) and more recently Orai3 has been associ-
ated with cell proliferation (Faouzi et al., 2011, 2013; Ay et al.,
2013; Borowiec et al., 2014). Orai3 has also been have shown
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FIGURE 6 | Effect of IL-1β on Orai1 protein expression in primary
hUSMCs. Serum-deprived primary hUSMCs were incubated in the
presence or absence of 10 ng/ml IL-1β for 24 h. Whole cell lysates were
assessed for Orai1 protein expression. Data are expressed relative to
b-actin protein expression, (cells from n = 8 patients).
to contribute to store-independent arachidonic acid-regulated
Ca2+ (ARC) channel activity (Mignen et al., 2008). More recently,
Thompson et al. (2010) reported that Orai3 subunits in a het-
eropentamer are responsible for the switch in selectivity from
a SOC channel to an ARC channel. There are also reports of a
novel SOC channel encoded by Orai3 (Motiani et al., 2010). The
significance of high Orai3 expression in cultured USMCs in rela-
tion to SOCE remains to be determined, but this observation
fits with some of our preliminary evidence for an arachidonic
acid-sensitive modulated calcium pathway in primary cultured
USMCs (data not shown).
Orai1-3 mRNA expression profiles in our primary cultured
cells (P0 and P2) conflicts with that reported by Murtazina et al.
(2011). There data suggested that that Orai1 was the predom-
inant transcript in cultured pregnant myometrial cells (P3-P9)
and immortalized cells derived from pregnant and non-pregnant
human myometrium (Orai1 > Orai2/3). It is likely that the dif-
ference in cell culture protocols account for this. For example,
Murtazina et al. (2011) maintained cells in culture for a long
period of time prior to experimentation (P3-9) compared to our
study (P0 and P2) and it is not clear whether cells were growth
arrested prior to study.
The functional impact of differences in tissue and cell STIM
and Orai isoform profiles requires consideration. Scrimgeour
et al. (2009) suggest that differential expression of STIM and
Orai proteins can result in altered CRAC currents (ICRAC). The
same study suggested that cells expressing a low Orai1: STIM1
ratio produced ICRAC with strong fast Ca2+ dependent inacti-
vation whilst cells expressing a high Orai1:STIM1 ratio produce
ICRAC with strong activation and negative potentials. Murtazina
et al. (2011) showed that STIM1 and Orai1-3 knockdown atten-
uated cyclopiazonic acid (CPA) and oxytocin-induced calcium
entry knockdown in immortalized and primary cultured human
myometrial cells. These data supports a functional role for STIM
and Orai in SOCE in human myometrium.
We also detected differences in the Orai: STIM mRNA ratio in
human pregnant tissue compared to cells. Notably in our study,
the endogenous Orai1:STIM1 ratio was low in primary cultured
cells (P0∼1:35; P2∼1:43) compared to pregnant humanmyome-
trial tissue (1:10) indicating the likelihood of different SOCE
currents in native tissue vs. cells maintained in culture. In non-
pregnant hUSMCs the ratio was different again (∼1:1.5); higher
to that in cells originating from pregnant women.
Previously, we reported that IL-1β induced a significant
enhancement of basal calcium entry and SOC, in tandem with
TRPC3, in primary hUSMCs. However, only Orai1 was increased
by IL-1β treatment. IL-1β induced a significant transient increase
in Orai1 mRNA which was in most tissues associated with a rise
in protein expression. A differential enhancement of Orai1 pro-
tein could in theory shift the STIM1:Orai1 ratio and potentially
calcium current characteristics. However, it must be noted that
a rise in Orai1 mRNA expression was not detected in tissues
from women pre and post labor onset; this potentially suggests
that inflammation does not influence expression of this isoform
in vivo.
In summary, we demonstrate the presence of novel proteins
(STIM/Orai) in pregnant human myometrium (preterm and
term) indicating a potential involvement in SOC entry in these
tissues. STIM1 and Orai2 appear to be the dominant isoforms
in pregnant human myometrium. The observation that IL-1β
increased Orai1 mRNA expression warrants further investigation
of the functional impact of this isoform. The importance of these
specific proteins to humanmyometrial contractility remains to be
determined.
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